tiprankstipranks

New Portfolio - New Portfolio

sumeet.jain@gmail.com

New Portfolio
Individual Investor
Ranked #273,922 out of 743,457 TipRanks' Investors
Success Rate
50%
223 out of 449
profitable transactions
Average Return
8.13%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▼ 7.83%
6-Month Return▲ 7.02%
12-Month Return▲ 21.11%
YTD Return▲ 3.89%
Total Return▲ 63.46%

Best Trade

Opened at
Closed at
Gain▲ 447.04%

Bio

Performance

18.25%0-18.25%
▲ 5.14%
▲ 4.57%
▲ 15.00%
Dec 2023
▼ 1.87%
▲ 1.59%
▼ 6.65%
Jan 2024
▲ 14.08%
▲ 5.22%
▲ 18.25%
Feb 2024
▲ 5.05%
▲ 3.27%
▲ 1.71%
Mar 2024
▼ 12.40%
▼ 4.03%
▼ 7.26%
Apr 2024
▲ 11.46%
▲ 5.06%
▲ 6.71%
May 2024
▼ 2.25%
▲ 3.53%
▼ 6.24%
Jun 2024
▲ 0.26%
▲ 0.21%
▼ 0.28%
Jul 2024
TipRanks AverageS&P 500Investor Portfolio
▲ 5.14%▲ 4.57%▲ 15.00%
▼ 1.87%▲ 1.59%▼ 6.65%
▲ 14.08%▲ 5.22%▲ 18.25%
▲ 5.05%▲ 3.27%▲ 1.71%
▼ 12.40%▼ 4.03%▼ 7.26%
▲ 11.46%▲ 5.06%▲ 6.71%
▼ 2.25%▲ 3.53%▼ 6.24%
▲ 0.26%▲ 0.21%▼ 0.28%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Global-e Online
▲ 0.80%
5
Close
Jun 24, 2024
Credo Technology Group Holding Ltd
▲ 131.52%
3
Close
May 31, 2024
JD
▲ 37.36%
6
Close
May 20, 2024
NetEase
▲ 10.71%
6
Close
May 15, 2024
AbCellera Biologics
▼ 22.69%
11
Close
May 15, 2024
MINISO Group Holding
▲ 29.56%
8
Close
May 07, 2024
Verve Therapeutics
▼ 48.15%
6
Close
May 07, 2024
Harmony Biosciences Holdings
▼ 7.54%
4
Close
Apr 26, 2024
Catalyst Pharma
▲ 0.10%
5
Close
Apr 26, 2024
Meta Platforms
4.39%
▲ 59.30%
3
Buy
Apr 25, 2024
Relay Therapeutics
2.31%
▼ 15.68%
15
Buy
Apr 25, 2024
Rapid7
▼ 12.69%
3
Close
Apr 25, 2024
Li Auto
1.17%
▼ 30.59%
11
Buy
Apr 25, 2024
Bowlero Corp. Class A
▼ 9.22%
5
Close
Apr 25, 2024
Intrusion
0.2%
▼ 64.49%
13
Buy
Apr 25, 2024
Inhibikase Therapeutics
0.6%
▼ 46.36%
20
Buy
Apr 25, 2024
Janux Therapeutics Inc
▲ 366.97%
5
Close
Apr 25, 2024
New Oriental Education Tech
0.6%
▲ 16.64%
4
Buy
Apr 24, 2024
Cantaloupe
▼ 5.30%
9
Close
Apr 24, 2024
Syros Pharmaceuticals
2.09%
▲ 1.65%
9
Buy
Apr 20, 2024